Skip to main content

Assessment of Disease Activity, Structural Damage, and Function in Rheumatoid Arthritis

  • Protocol
  • First Online:
Rheumatoid Arthritis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2766))

  • 283 Accesses

Abstract

The primary goal in the treatment of rheumatoid arthritis (RA) is to control disease activity, prevent structural damage in joints, and normalize function. Therefore, reliable tools are needed to disease activity, physical function, and radiographic progression in RA. We herein describe methods recently used to assess RA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Emery P, Kavanaugh A, Bao Y et al (2015) Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis? Ann Rheum Dis 74:2165–2174

    Article  CAS  PubMed  Google Scholar 

  2. Smolen JS, Breedveld FC, Burmester GR et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75:3–15

    Article  PubMed  Google Scholar 

  3. Prevoo ML, van ‘t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  CAS  PubMed  Google Scholar 

  4. Smolen JS, Breedveld FC, Schiff MH et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42:244–257

    Article  CAS  PubMed  Google Scholar 

  5. Aletaha D, Nell VP, Stamm T et al (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7:R796–R806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Felson DT, Anderson JJ, Boers M et al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727–735

    Article  CAS  PubMed  Google Scholar 

  7. Van der Heijde DM (1996) Plain x-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol 10:435–453

    Article  PubMed  Google Scholar 

  8. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 18:481–491

    Article  CAS  PubMed  Google Scholar 

  9. Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9:789–793

    CAS  PubMed  Google Scholar 

  10. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  11. Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727–1736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Felson DT, Smolen JS, Wells G et al (2011) American College of Rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70:404–413

    Article  PubMed  Google Scholar 

  13. Studenic P, Aletaha D, de Wit M et al (2023) American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision. Arthritis Rheumatol 82:74–80

    Google Scholar 

  14. Schwieterman WD (2008) Issues in the design of new clinical trials for rheumatoid arthritis therapeutics. Nat Clin Pract Rheumatol 4:641–648

    Article  CAS  PubMed  Google Scholar 

  15. Ravindran V, Rachapalli S (2011) An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials. Clin Rheumatol 30:1–6

    Article  PubMed  Google Scholar 

  16. Tugwell P, Boers M (1993) OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol 20:528–530

    CAS  PubMed  Google Scholar 

  17. Boini S, Guillemin F (2001) Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis 60:817–827

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Ishizaki .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Ishizaki, J., Hasegawa, H. (2024). Assessment of Disease Activity, Structural Damage, and Function in Rheumatoid Arthritis. In: Liu, S. (eds) Rheumatoid Arthritis. Methods in Molecular Biology, vol 2766. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3682-4_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3682-4_33

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3681-7

  • Online ISBN: 978-1-0716-3682-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics